Raymond James & Associates’s Abbott ABT Stock Holding History

Raymond James & Associates’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-30,500	Closed	-$20K	–	3582
2018 Q1	$20K	Buy	30,500 +2,400	+9%	+$145K	﹤0.01%	3380
2017 Q4	$15K	Sell	28,100 -34,200	-55%	-$1.9M	﹤0.01%	3357
2017 Q3	$103K	Buy	62,300 +3,400	+6%	+$171K	﹤0.01%	3175
2017 Q2	$236K	Sell	58,900 -4,500	-7%	-$204K	﹤0.01%	2883
2017 Q1	$4K	Buy	63,400 +3,800	+6%	+$164K	﹤0.01%	3266
2016 Q4	$1K	Sell	59,600 -84,600	-59%	-$3.35M	﹤0.01%	3224
2016 Q3	$160K	Buy	+144,200	New	+$6.18M	﹤0.01%	2911

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Raymond James & Associates's ABT Position: Q3 2024 in Review

Raymond James & Associates increased its Abbott (ABT) stake by 7% in Q3 2024, buying an estimated $24.2M and bringing the position to 3,372,735 shares worth $385M. The position accounts for 0.23% of the portfolio, ranked #76.

Raymond James & Associates first reported a position in ABT in Q2 2013 and has held it in 46 quarters since. The position peaked at $422M in Q4 2021. 2,896 funds tracked by Wall St. Rank hold ABT as of Q3 2024.

Raymond James & Associates held 3,372,735 shares of Abbott worth $385M as of Q3 2024.
Raymond James & Associates bought 220,777 Abbott shares in Q3 2024, an estimated $24.2M.
Abbott made up 0.23% of Raymond James & Associates's portfolio in Q3 2024, its #76 holding.
Raymond James & Associates first reported a position in Abbott in Q2 2013 and has held it in 46 quarters since.
Raymond James & Associates's Abbott position peaked at $422M in Q4 2021.
2,896 funds tracked by Wall St. Rank held Abbott as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.